4.7 Article

Dietary supplementation with American ginseng dietary fiber ameliorates intestinal mucosal barrier injury in immunosuppressed mice

期刊

FOOD BIOSCIENCE
卷 56, 期 -, 页码 -

出版社

ELSEVIER
DOI: 10.1016/j.fbio.2023.103237

关键词

American ginseng dietary fiber; Cyclophosphamide; Immunosuppression; Intestinal mucosal barrier injury; TLR4/NF-kappa B signaling pathway

向作者/读者索取更多资源

This study investigated the protective effect of American ginseng dietary fiber (AGDF) on intestinal mucosal barrier injury in immunosuppressed mice. The results showed that AGDF could enhance immunity and stabilize the intestinal mucosal barrier, suggesting its potential as a dietary supplement for preventing and treating intestinal mucosal barrier injury.
Dietary fiber is an important component of healthy eating patterns. Although American ginseng (Panax qui-quefolium L.) is often used to improve body immunity, less attention has been paid to American ginseng dietary fiber (AGDF) in this regard. The aim of this study was to investigate the protective effect of AGDF on intestinal mucosal barrier injury induced by cyclophosphamide (CTX) in immunosuppressed mice and the underlying mechanism. The results showed that AGDF could increase immune organ index and enhance immunity of immunosuppressed mice, such as DTH response, lymphocyte transformation and proliferation and NK effector cell activity. At the same time, AGDF could restore the proportion of CD4(+)/CD8(+) T lymphocytes induced by CTX to different extents, and promote the secretion of immunoglobulin IgG. More importantly, AGDF could up-regulate the contents of TNF-alpha, IFN-gamma, IL-6 and IL-1 beta in serum and intestine of immunosuppressed mice, pro -mote the secretion of cytokines and regulate the homeostasis balance between Th1/Th2 cytokines. It also upregulated the expression of tight junction proteins occludin, claudin-1 and ZO-1, and alleviated the degree of CTX-induced damage to the intestinal mucosal barrier. Meanwhile, AGDF could reduce intestinal epithelial cell apoptosis by activating TLR4/NF-kappa B signaling pathway, improving the phosphorylation of JNK and p38 signaling molecules, which may be the potential mechanism by which AGDF ameliorates intestinal mucosal injury in immunosuppressed mice. Therefore, AGDF may be used as a dietary supplement to prevent and treat intestinal mucosal barrier injury caused by CTX.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据